SMEInst-05-2016-2017
SMEInst-05-2016-2017
107 projects · €112,881,738 total EU contribution (project-level) · 108 participating organizations · 21 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€112,881,738
Countries active
Participant organizations by country (headquarters in CORDIS).
- UK (15)
- Spain (13)
- France (11)
- Italy (10)
- SE (10)
- IL (8)
- Germany (7)
- Netherlands (6)
- PT (6)
- DK (4)
- IE (3)
- PL (3)
- AT (2)
- IS (2)
- NO (2)
- BE (1)
- CZ (1)
- EE (1)
- HU (1)
- SI (1)
- TR (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- AENITIS TECHNOLOGIES2 projects · FR
- EBERS2 projects · ES
- THE ZEBRAFISH LAB2 projects · ES
- METAFORA BIOSYSTEMS2 projects · FR
- SYMCEL2 projects · SE
- 2CUREX A/S1 projects · DK
- 2CUREX GMBH1 projects · DE
- AMADIX1 projects · ES
- AEQUOR1 projects · UK
- AGLARIS1 projects · UK
- ALLTOX1 projects · IT
- ALTRATECH LIMITED1 projects · IE
Projects
Page 1 of 11
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Smart Multifunctional silica-based Nanoparticles for Targeted Therapy NanoSil4Cancer · 736632 | H2020 | €50,000 | €71,429 | Details |
Improving kidney transplantation outcome with Renaparin® for patients with End-Stage Renal Disease by attenuating graft ischemia reperfusion injury Renaparin · 756195 | H2020 | €2,362,681 | €2,362,681 | Details |
Normothermic perfusion devices for renal and hepatic preservation and viability assessment NORMOPERF · 729703 | H2020 | €50,000 | €71,429 | Details |
Cost-effective automated equipment for life sciences and healthcare laboratories LiST · 761595 | H2020 | €50,000 | €71,429 | Details |
CalScreener® – an innovative device for Bacterial Analysis and Diagnostics through Growth and Energy-release in Real-time BADGER · 784514 | H2020 | €3,572,568 | €3,572,568 | Details |
Clinical validation and commercialization of innovative immunostimulating Interstitial Laser Thermotherapy INTHER · 725151 | H2020 | €2,136,358 | €2,136,358 | Details |
EUROpean clinical validation of a new ex vivo eXpanded stem cell theraPy for cArdiac regeNeration after acute myocarDial infarction: EUROXPAND EuroXpand · 806595 | H2020 | €5,000,000 | €5,000,000 | Details |
Innovative combination therapy against bladder cancer INNOBCT · 761906 | H2020 | €50,000 | €71,429 | Details |
ONCOlogic patient profiling and personalized treatment through SMART bedside diagnostics Oncosmart · 744110 | H2020 | €50,000 | €71,429 | Details |
Cost and time-effective universal medical device for treatment of onychomycosis by combining several technologies OZONELASER · 729433 | H2020 | €50,000 | €71,429 | Details |